We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharma giants Teva Pharmaceuticals and Merck are currently in talks about adding their significant manufacturing capabilities to COVID-19 vaccine production, though specifics have not been disclosed at this point. Read More
Pfizer said it can cut the time it takes to manufacture its COVID-19 vaccine by almost half from 110 days to an estimated 60 days, a change that should significantly increase the speed of U.S. vaccinations. Read More
GlaxoSmithKline previously announced it would delay a phase 2b trial of its adjuvanted vaccine candidate developed with Sanofi following lackluster results. Read More
Jazz Pharmaceuticals is set to acquire GW Pharmaceuticals, a UK drugmaker known for its CBD products Epidiolex (cannabidiol) and Sativex (nabiximols), for a whopping $7.2 billion. Read More
Bristol Myers Squibb (BMS) has struck a deal with Rockefeller University for the global rights to a monoclonal antibody being developed by the university to treat COVID-19. Read More